免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

CLAROX plus(型號:VX-100)

K 號:K221417 · 2022-09-13

申請人Vsi Co., Ltd.
決定日期2022-09-13
產品代碼IZL
諮詢委員會RA
決定相當於

器材摘要

CLAROX plus (Model: VX-100) is the device name listed in this FDA 510(k) record. The listed applicant is Vsi Co., Ltd.. It received FDA 510(k) clearance on 2022-09-13 under 510(k) number K221417. The device is classified under product code IZL. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the CLAROX plus (Model: VX-100)?

CLAROX plus (Model: VX-100) is a medical device that received FDA 510(k) clearance on 2022-09-13. The listed applicant is Vsi Co., Ltd.. The 510(k) number is K221417.

When did CLAROX plus (Model: VX-100) receive FDA 510(k) clearance?

CLAROX plus (Model: VX-100) received FDA 510(k) clearance on 2022-09-13, under 510(k) number K221417.

Who is the listed applicant for CLAROX plus (Model: VX-100)?

The FDA 510(k) record lists Vsi Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CLAROX plus (Model: VX-100)?

The FDA product code for CLAROX plus (Model: VX-100) is IZL.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Vsi Co., Ltd. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:IZL)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑